Simplify Asset Management’s Abeona Therapeutics ABEO Stock Holding History

Simplify Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.13M	Sell	345,416 -162,572	-32%	-$893K	0.03%	58
2026 Q1	$2.28M	Buy	507,988 +7,646	+2%	+$38.2K	0.03%	51
2025 Q4	$2.64M	Sell	500,342 -64,667	-11%	-$326K	0.04%	55
2025 Q3	$2.98M	Buy	565,009 +6,425	+1%	+$40.7K	0.05%	39
2025 Q2	$3.17M	Buy	558,584 +150,000	+37%	+$854K	0.16%	33
2025 Q1	$1.94M	Hold	408,584	–	–	0.07%	50
2024 Q4	$2.28M	Hold	408,584	–	–	0.11%	47
2024 Q3	$2.58M	Hold	408,584	–	–	0.12%	47
2024 Q2	$1.73M	Buy	+408,584	New	+$2.08M	0.12%	51

Other funds holding ABEO

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Simplify Asset Management's ABEO Position: Q2 2026 in Review

Simplify Asset Management reduced its Abeona Therapeutics (ABEO) stake by 32% in Q2 2026, selling an estimated $893K and leaving 345,416 shares worth $2.13M. The position accounts for 0.03% of the portfolio, ranked #58.

Simplify Asset Management first reported a position in ABEO in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.17M in Q2 2025. 6 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

Simplify Asset Management held 345,416 shares of Abeona Therapeutics worth $2.13M as of Q2 2026.
Simplify Asset Management sold 162,572 Abeona Therapeutics shares in Q2 2026, an estimated $893K.
Abeona Therapeutics made up 0.03% of Simplify Asset Management's portfolio in Q2 2026, its #58 holding.
Simplify Asset Management first reported a position in Abeona Therapeutics in Q2 2024 and has held it in 9 quarters since.
Simplify Asset Management's Abeona Therapeutics position peaked at $3.17M in Q2 2025.
6 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.